“NON-INVASIVE MONITORING OF EGFR MUTATIONS IN NONSMALL CELL LUNG CANCER (NSCLC) DURING TARGETED THERAPY: STATE OF THE ART AND OUR EXPERIENCE” (2016) Voprosy onkologii, 62(4), pp. 513–518. doi:10.37469/0507-3758-2016-62-4-513-518.